Marker Therapeutics Announces Board Resignation

Houston-based biopharmaceutical company Marker Therapeutics, Inc., with a market capitalization of $20.45 million, reported a change in its board composition earlier this week. On Thursday, the firm announced the resignation of Mr. John Wilson from its Board of Directors, effective January 24, 2025. The details surrounding Mr. Wilson's departure have not been disclosed, and the company has not named a successor at this time.

You May Also Be Interested In

• Evercore ISI Starts SpaceX (SPCX) at Outperform
• Raymond James stays sidelined on Roblox Corp. (RBLX) amid rollout out of kids/select accounts
• Tower Semiconductor plans $3B Japan expansion for photonics capacity